Corindus Technology Successfully used in Multiple Live Complex Robotic-Assisted Coronary Interventions at Transcatheter Cardiovascular Therapeutics 2018

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that its CorPath GRX System was used for multiple complex robotic-assisted percutaneous coronary interventions (PCI) at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2018 Conference. In the first case at University of Washington Medical Center, Dr. William Lombardi, a high volume chronic total occlusion (CTO) PCI operator, performed the first live transmission of a hybrid CTO PCI using both manual and robotic techniques to successfully treat a patient suffering from a complete coronary artery blockage. Simultaneously, at UC San Diego, Dr. Ehtisham Mahmud performed a robotic-assisted CHIP (Complex Higher-Risk Indicated Patients) case utilizing multiple interventional devices. Both demonstrations were broadcast live during TCT to thousands of conference attendees. Recordings of the live cases can be viewed by visiting www.tctmd.com/tct2018.